Global Thyroid Cancer Diagnostics Market Size, Share & Growth is Projected to Reach USD 3.6 Billion by 2027 | BlueWeave
A study recently conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global thyroid cancer diagnostics market was worth USD 2.5 billion in 2020 and is further projected to reach USD 3.6 billion by 2027, at a CAGR of 5.3% during the forecast period (2021-2027). The market is driven by factors, such as the growing number of thyroid cases, increasing awareness among people, and technological advancements in the cancer diagnosis and treatment field. An increasing number of initiatives by governments and growing investment in research are also expected to create lucrative opportunities for the growth of the thyroid cancer diagnostics market during the forecast period.
Browse report URL for more information about global thyroid cancer diagnostics market @ https://www.blueweaveconsulting.com/report/global-thyroid-cancer-diagnostics-market
A growing number of thyroid cancer cases is expected to drive global thyroid cancer diagnostics market growth during the forecast period
The growing number of thyroid cancer cases around the world poses a significant challenge. According to the International Agency for Research on Cancer, there were 586,202 new thyroid cancer cases around the world in 2020 with 43,646 deaths. According to Cancer Research UK, an English charity that is registered in England and Wales, there are about 3,700 thyroid cancer cases every year, or about 10 each day.The charity further states that thyroid cancer incidence rates have increased by more than two-thirds (68%) in the UK over the last decade. Due to an increasing number of thyroid cancer cases around the world, the global thyroid cancer diagnostics market is projected to grow during the forecast period as the number of thyroid cancer cases increases.
The ever-increasing obese population is expected to create growth opportunities for the global thyroid cancer diagnostics market during the forecast period
Obesity is a modern pandemic that is affecting more and more people around the world. Obesity is well known to be linked to a variety of diseases, including cancers such as breast cancer, endometrial cancer, colon cancer, esophageal adenocarcinoma, and prostate cancer. Studies are now showing that obese people are also at a higher risk of thyroid cancer. According to the International Agency for Research on Cancer (IARC), people who are overweight or obese have a higher risk of developing thyroid cancer than those who are not. The body mass index (BMI) is a widely used measure of obesity, and a high BMI is associated with an increased risk of thyroid cancer. According to WHO, more than 2.8 million die every year due to obesity, and the prevalence of obesity is increasing at a rapid rate. The rise in obesity is likely to lead to higher rates of thyroid cancer, which will benefit market growth during the forecast period.
Browse TOC with Facts and Figures @ https://www.blueweaveconsulting.com/report/global-thyroid-cancer-diagnostics-market/report-sample
The Papillary Carcinoma segment accounted for the largest share in the global thyroid cancer diagnostics market in 2020
The global thyroid cancer diagnostics market is divided into papillary carcinoma, follicular carcinoma, and others. Papillary carcinoma dominated the global thyroid cancer diagnostics market in 2020 and held a dominant market share as it is the most prevalent thyroid cancer. Because papillary carcinoma can easily spread to other organs, early diagnosis is always beneficial. It manifests as an irregular solid or cystic mass or nodule in normal thyroid parenchyma and can be treated surgically or non-surgically. Additionally, it has a close to 100% 5-year survival rate, according to the American Society of Clinical Oncology (ASCO).
Global Thyroid Cancer Diagnostics Market: Regional insights
The global thyroid cancer diagnostics market is divided into the Asia-Pacific (APAC), North America, Europe, South America, and the Middle East & Africa regions. Because of the high number of thyroid cancer cases in the country, North America dominated the global thyroid cancer diagnostics market in 2020.According to an estimate from the American Cancer Society, there will be around 44,280 new thyroid cancer cases in the USA and around 2,200 new deaths from thyroid in 2021. Other factors contributing to North America's dominant share in the global thyroid cancer diagnostics market include the emergence of more sensitive diagnostic procedures such as CT or MRI scans, growing awareness, and the presence of global leaders in the regions.
COVID-19 Impact on Global Thyroid Cancer Diagnostics Market
The COVID-19 affected the global thyroid cancer diagnostics market negatively as the number of diagnosed cases went down in 2020. The focus on COVID-19 resulted in delays in cancer screening, diagnosis, and treatment because of reduced access to health care. The decrease in cancer diagnoses will likely be followed by an increase in late-stage diagnoses and preventable cancer deaths. The American Cancer Society and other organizations recommended routine cancer screenings and other elective medical procedures for the timely diagnosis of thyroid cancer during the pandemic. However, lockdown and travel bans made it difficult for people to get a cancer diagnosis during the pandemic. Furthermore, the market recovery was halted in the first and second quarters of 2021 as a result of the second wave of the COVID-19 and the emergence of deadlier variants of the COVID-19. Moreover, the looming threat of the third wave of the COVID-19 in the fourth quarter of 2021 and growing cases of delta-variants are expected to affect the recovery of the global thyroid cancer diagnostics market.
The Leading Players in the Global Thyroid Cancer Diagnostics Market are Abbott, F.Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Bio-Rad Laboratories Inc., Agilent Technologies, Inc., Illumina, Inc., Hologic, Inc., Leica Biosystems Nussloch GmbH, Fujifilm Holding Corporation, Merck KGaA, BeckmanCoulters inc, Randox Laboratories Ltd and other prominent players. Companies operating in the thyroid cancer diagnostics market are constantly striving to grow their market share through increasing customer awareness, launching new developments, improving existing technology, and developing new methods and techniques.
Request For Free Sample Report @ https://www.blueweaveconsulting.com/report/global-thyroid-cancer-diagnostics-market/report-sample
In August 2021, HalioDxcompleted the acquisition of Veracyte, Inc. for USD 304 million to strengthen its presence within international markets as well as expand its scientific and diagnostic capabilities into eight of the 10 most prevalent cancers in the U.S. As a global company in genomic diagnostics, Veracyte offers tests for lung, prostate, and heart cancers, as well as thyroid cancer, bladder, and idiopathic pulmonary fibrosis diagnosis.
In December 2020, Roche and Blueprint Medicine’s Gavre to got approval from FDA in advanced or metastatic RET-mutant medullary or RET fusion-positive thyroid cancer. Gavre to already had approval for non-small cell lung cancer that bears an abnormality in the RET gene. The latest approval will put Roche and Blueprint Medicine’s Gavreto directly against Lilly’s Retevmo, which got FDA approval in May 2020.
Don’t miss the business opportunity of the global thyroid cancer diagnostics market. consult our analysts to gain crucial insights and facilitate your business growth.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global thyroid cancer diagnostics market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends, along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Please find some related topics:
BlueWeave Consulting & Research Pvt. Ltd
US: +1 866 658 6826 | +1 425 320 4776
UK: +44 1865 60 0662
Email – email@example.com
Linked In Page: https://www.linkedin.com/company/blueweaveconsulting/
112 - H160 - BSI Business Park Sector - 63, Noida U.P. - India
BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Thyroid Cancer Diagnostics Market Size, Share & Growth is Projected to Reach USD 3.6 Billion by 2027 | BlueWeave here
News-ID: 2364747 • Views: 194
More Releases from BlueWeave Consulting & Research Pvt Ltd.
United States Enhanced Water Market Size, Share Growth is Projected to Growing a …
The United States enhanced water market is growing at high rate because of the rising health awareness and the need for additional nutritional supplements in the body due to a busy lifestyle.... A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the US enhanced water market was worth USD 2,131.0 million in the year 2020. The data yielded by the study reveals that the
Global Electronic Bill Presentment and Payment (EBPP) Market Size & Share is Gro …
Electronic bill presentment and payment (EBPP) market is being driven by factors such as globalization, businesses expanding overseas, and consumers increasingly using plastic money. Market growth is also driven by the use of high-speed internet access on smart phones... A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global electronic bill presentment and payment (EBPP) market was worth 18.5 number of bills in
Global Fatty Alcohol Market Size & Share is Predicted to Garner USD 8.4 Billion …
The global fatty alcohol market is growing at a high CAGR because of the increasing demand for bio-based renewable products to promote sustainability and control dependence on non-renewable products such as petrochemicals... A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global fatty alcohol market was worth USD 5.5 billion in the year 2020. The market is estimated to grow at a CAGR
Global Medical Goggle Market Size, Share & Growth is Projected to Grow at a CAGR …
The global medical goggle market is growing at a high CAGR because of the increasing demand for surgical procedures and prevalence of infectious diseases and stringent regulations regarding the safety of healthcare workers... A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global medical goggle market was worth USD 443.4 million in the year 2020. The data generated by the study reveals that
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and